Month: October 2024

Louisiana’s first-in-the-nation law listing the abortion medications mifepristone and misoprostol as “controlled dangerous substances” took effect Tuesday, triggering fears among health-care providers and pharmacists that routine care may be worsened

Despite a continuous decline in the rate of breast cancer deaths in the United States, the incidence of the disease has increased, especially among younger ages, and significant racial disparities